One of the primary innovations that occupied the spotlight during the COVID-19 pandemic has been mRNA technology, which is the platform on which the most effective vaccines have been built, and which has many potential applications within and far beyond infectious disease. The pandemic also accelerated the creation and adoption of platforms for data analytics and digital health that enabled rapid learning and patient-centric care. What is the future promise of platforms such as these? What platforms could have a significant impact on medical product innovation and the healthcare ecosystem?

Moderator

Allison Aubrey
Health Correspondent, NPR

Speakers

Chris Austin
CEO-Partner, Flagship Pioneering

Gianrico Farrugia
President and CEO, Mayo Clinic

Phil Febbo
Chief Medical Officer and Senior Vice President, Illumina

Rick Klausner
Founder, Chief Scientist, Altos Labs

Alice Zhang
CEO and Co-Founder, Verge Genomics